Farms.com Home   News

Federal Transport Minister To Hold Talks With Saskatchewan Farm Groups

 
The federal transport minister has scheduled a meeting in Saskatchewan to discuss grain movement with farm groups.
 
Transportation Minister Marc Garneau will hold his first face-to-face meeting with grain producers on October 20th in Saskatoon.
 
It will give farm organizations an opportunity to discuss the ongoing review of the Canada Transportation Act.
 
The CTA review’s final report included a recommendation that the Maximum Revenue Entitlement or MRE be scrapped within seven years.
 
The MRE places a cap on the amount of money railways can charge for shipping grain.
 
Norm Hall, President of the Agricultural Producers Association of Saskatchewan, says the October 20th meeting with Garneau will be very important.
 
He says if the MRE is scrapped, studies show farmers could see a 25 to 30 per-cent increase in grain freight rates, meaning a 300 to 400 million dollar increase in freight costs per year to prairie farmers.
 
Source : CKRM

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.